The Cystic Fibrosis Foundation helped develop a treatment, then sold its share of the patent rights to a company that is charging almost $400,000 per year. Most of the patients can't afford that.

Other countries' national health systems will negotiate a price that will probably be far lower. US law, paid for by Big Pharma, does not allow this.